Eli Lilly and Company
DNA molecules encoding anti-IL-33 antibodies

Last updated:

Abstract:

Antibodies which bind and neutralize human IL-33, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with allergic disease including treating atopic dermatitis.

Status:
Grant
Type:

Utility

Filling date:

25 Oct 2019

Issue date:

9 Feb 2021